Activation of the endocannabinoid system mediates cardiac hypertrophy induced by rosiglitazone
{{output}}
Rosiglitazone (RSG) is a synthetic agonist of peroxisome proliferator-activated receptor-γ (PPARγ), which plays a central role in the regulation of metabolism. Meta-analyses have suggested that RSG is associated with increased cardiovascular risk. However, t... ...
